Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-β): A phase I trial

Human Gene Therapy

Volumn 12, Issue 1, 2001, Pages 97-113

  Eck, S L ^a   Wilson, J M ^a   Propert, K ^a   Alavi, J B ^a   Judy, K ^a   Phillips, P ^a   Alavi, A ^a   Hackney, D ^a   Cross, P ^a   Hughes, J ^a   Gao, G P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

ADENOVIRUS; ADULT; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; PHASE 1 CLINICAL TRIAL; RECURRENT CANCER; REVIEW; TOXICITY TESTING; VIRUS RECOMBINANT;

ADENOVIRIDAE; ADOLESCENT; ADULT; ANIMALS; BRAIN NEOPLASMS; GENE EXPRESSION; GENE THERAPY; GLIOMA; HUMANS; INTERFERON-BETA; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; RECURRENCE; RISK ASSESSMENT; SAFETY; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOVIRIDAE;

EID: 0035172428     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303401451013     Document Type: Review

References (24)

1. Pharmacokinetics and pharmacodynamics of interferon beta-1a (IFNβ-1a) in healthy volunteers after intravenous, subcutaneous and intramuscular injection
2. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors
3. Adenovirus-mediated p53 gene delivery inhibits 9l glioma growth in rats
4. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
5. Gene therapy for malignant neoplasms of the CNS
6. Immunobiology of gliomas: New perspectives for therapy
7. Clinical protocol: Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: A phase I trial
8. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
9. A phase I study of a new recombinant human β-interferon (BC9015) for the treatment of patients with recurrent gliomas
10. Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma
11. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival
12. Gene therapy: Adenovirus vectors
13. Neoplasms of the Central Nervous System
14. Defective herpes simplex virus vectors expressing thymidine kinase for the treatment of malignant glioma
15. Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant β-interferon and hyperfractionated radiation therapy. A Children's Cancer Group phase I/II study
16. Gene therapy of malignant glioma via inhibition of tumor angiogenesis
17. Angiogenesis in malignant gliomas
18. Interferon-β gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice
19. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
20. Intracranial administration of adenovirus expressing HSVTK in combination with ganciclovir produces a selflimited, dose-dependent inflammatory response
21. Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth
22. Induction of antitumor immunity by intracerebrally implanted rat C6 glioma cells genetically engineered to secrete cytokines
23. Interferon-containing controlled release polymers for localized cerebral immunotherapy
24. Methods of gene delivery